Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when PMV Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.

Get PMVP alerts

About David H. Mack

David H. Mack is recorded as Board Member at PMV Pharmaceuticals, Inc. (PMVP) since January 1, 2013 and CEO at PMV Pharmaceuticals, Inc. (PMVP). The newest filing on record that lists David H. Mack as CEO and Board Member at PMV Pharmaceuticals, Inc. (PMVP) is dated April 22, 2026. The proxy statement of PMV Pharmaceuticals, Inc. reports total compensation of $1,665,191 for David H. Mack in fiscal 2025, including a base salary of $628,461. Disclosed compensation is on record for 7 fiscal years. PMV Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at PMV Pharmaceuticals, Inc. includes Michael Carulli (CFO), Robert Ticktin (COO), Arnold Levine (Board Member) and 7 others.

Affiliation history

Company network

Leadership on record at PMV Pharmaceuticals, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 PMV Pharmaceuticals, Inc. (PMVP) $628,461 $1,665,191
2024 PMV Pharmaceuticals, Inc. (PMVP) $607,208 $4,760,281
2023 PMV Pharmaceuticals, Inc. (PMVP) $586,083 $2,209,795
2022 PMV Pharmaceuticals, Inc. (PMVP) $563,750 $3,576,440
2021 PMV Pharmaceuticals, Inc. (PMVP) $545,454 $3,541,855
2020 PMV Pharmaceuticals, Inc. (PMVP) $494,647 $1,314,113
2019 PMV Pharmaceuticals, Inc. (PMVP) $461,250 $628,110

Recent activity

No call appearances or filed executive changes recorded yet.